Bacterial alkaloids mitigate seizure-induced hippocampal damage and spatial memory deficits

Experimental Neurology

Volumn 141, Issue 2, 1996, Pages 287-296

  Smith Swintosky, Virginia L ^a   Kraemer, Philipp J ^b   Bruce, Annadora J ^a   McCants, Nicole ^a   Maki, Andrew ^b   Brown, Russell W ^b   Alcala, Mona ^b   Goodman, Yadong ^a   Slevin, John T ^b   Mattson, Mark P ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; EXCITOTOXIN; K 252A; K 252B; KAINIC ACID; STAUROSPORINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EPILEPSY; HIPPOCAMPUS; HISTOLOGY; IMMUNOBLOTTING; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SEIZURE; SPATIAL MEMORY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030272540     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0163     Document Type: Article

References (46)

1. 1. BEN-ARI, Y. 1985. Limbic seizures and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14: 375-403.
2. 2. CENDES, R., F. ANDERMANN, S. CARPENTER, R. J. ZATORRE, AND N. R. CASHMAN. 1995. Temporal lobe epilepsy caused by domoic acid intoxication: Evidence for glutamate receptor-mediated excitotoxicity in humans. Ann. Neural. 37: 123-126.
3. 3. CHAO, M. V. 1992. Neurotrophin receptors: A window into neuronal differentiation. Neuron 9: 583-593.
4. 4. CHENG, B. AND M. P. MATTSON. 1992. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J. Neurosci. 12: 1558-1566.
5. 5. CHENG, B. AND M. P. MATTSON. 1995. PDGFs protect hippocampal neurons against energy deprivation and oxidative injury: Evidence for induction of antioxidant pathways. J. Neurosci. 15: 7095-7104.
6. 6. CHENG, B., S. W. BARGER AND M. P. MATTSON. 1994. Staurosporine, K252a and K252b stabilize calcium homeostasis and promote survival of CNS neurons in the absence of glucose. J. Neurochem. 62: 1319-1329.
7. 7. ELLIOTT, E., M. P. MATTSON, P. VANDERKLISH, G. LYNCH, I. CHANG AND R. M. SAPOLSKY. 1993. Corticosterone exacerbates kainate-induced alterations in hippocampal tau immunoreactivity and spectrin proteolysis in vivo. J. Neurochem. 61: 57-67.
8. 8. GAYOSO, M. J., C. PRIMO, A. AL-MAJDALAWI, J. M. FERNANDEZ, M. GARROSO, AND C. INIQUEZ. 1994. Brain lesions and water-maze learning deficits after systemic administration of kainic acid to adult rats. Brain Res. 653: 92-100.
9. 9. GLICKSMAN, M. A., M. E. FORBES, J. E. PRANTNER AND N. T. NEPP. 1995. K252a promotes survival and choline acetyltransferase activity in striatal and basal forebrain neuronal cultures. J. Neurochem. 64: 1502-1512.
10. 10. GOODMAN, Y. AND M. P. MATTSON. 1994. Staurosporine and K-252 compounds protect hippocampal neurons against amyloid β-peptide toxicity and oxidative injury. Brain Res. 650: 170-174.
11. 11. HAMM, R. J., C. E. DIXON, D. M. GBADEBO, A. K SINGHA, L. W. JENKINS, B. G. LYETH AND R. L. HAYES. 1992. Cognitive deficits following traumatic brain injury produced by controlled cortical impact. J. Neurotrauma. 9:11-20.
12. 12. HARA, H., H. ONODERA, M. YOSHIDOMI, Y. MATSUDA, AND K. KOGURE. 1990. Staurosporine, a novel protein kinase C inhibitor, prevents post-ischemic neuronal damage in the gerbil and rat. J. Cereb. Blood Flow Metab. 10: 646-653.
13. 13. HELDIN, C. H. AND B. WESTERMARK. 1989. Platelet-derived growth factor: Three isoforms and two receptor types. Trends Genet. 5: 108-111.
14. 14. HELMSTAEDTER, C., C. E. ELGER, AND M. LENDT. 1994. Postictal courses of cognitive deficits in focal epilepsies. Epilepsia 35: 1073-1078.
15. 15. HOCHMAN, D. W., S. C. BARABAN, J. W. M. OWENS AND P. A. SCHWARTZKROIN. 1995. Dissociation of synchronization and excitability in furosemide blockade of epileptiform activity. Science 270: 99-102.
16. 16. KASE, H., K. IWAHASHI, S. NAKANISHI, Y. MATSUDA ET AL. 1987. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 142: 436-440.
17. 17. KNUSEL, B. AND F. HEPTI. 1992. K252 compounds: Modulators of neurotrophin signal transduction. J. Neurochem. 59: 1987-1996.
18. 18. KRAEMER, P. J. AND C. K. RANDALL. 1995. Spatial learning in preweanling rats trained in a Morris water maze. Psychobiology. 23:144-152.
19. 19. KRAEMER, P. J., R. W. BROWN, S. A. BALDWIN AND S. W. SCHEFP. 1996. Validation of a single-day Morris water maze procedure used to assess cognitive deficits associated with brain damage. Brain Res. Bull. 39: 17-22.
20. 20. LEES, G. AND W. LEONG. 1994. Synergy between diazepam and NBQX in preventing neuronal death caused by non-NMDA agonists. Neuroreport. 5: 2149-2152.
21. 21. LIPTON, S. A. 1993. Prospects for clinically tolerated NMDA antagonists: Open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci. 16: 527-532.
22. 22. MARONEY, A. C., L. LIPFERT, M. E. FORBES, M. A. GLICKSMAN, N. T. NEFF, R. SIMON AND C. A. DIONNE. 1995. K252a induces tyrosine phosphorylation of the focal adhesion kinase and neurite outgrowth in human neuroblastoma SH-SY5Y cells. J. Neurochem. 64:540-549.
23. 23. MATTSON, M. P. AND S. B. KATER. 1989. Excitatory and inhibitory neurotransmitters in the generation and degeneration of hippocampal neuroarchitecture. Brain Res. 478: 337-348.
24. 24. MATTSON, M. P. AND S. W. SCHEFF. 1994. Endogenous neuroprotection factors and traumatic brain injury: Mechanisms of action and implications for therapy. J. Neurotrauma 11: 3-33.
25. 25. MATTSON, M. P., B. CHENG AND V. L. SMITH-SWINTOSKY. 1993. Growth factor-mediated protection from excitotoxicity and disturbances in calcium and free radical metabolism. Sem. Neurosci. 5: 295-307.
26. 26. MATTSON, M. P., S. W. BARGER, B. CHENG, I. LIEBERBURG, V. L. SMlTH-SwiNTOSKY AND R. E. RYDEL. 1993. β-amyloid precursor protein metabolites and loss of neuronal calcium homeostasis in Alzheimer's disease. Trends Neurosci. 16: 409-415.
27. 2+]I and neurotoxicity, and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65: 1740-1751.
28. 28. MCDONALD, R. L. AND K. M. KELLY. 1993. Antiepileptic drug mechanisms of action. Epilepsia 34: S1-S8.
29. 29. MILLER, L. A., D. G. MUNOZ AND M. FINMORE. 1993. Hippocampal sclerosis and human memory. Arch. Neural. 50: 391-394.
30. 30. MONCADA, C., B. ARVIN, E. LE PEILLET, AND B. S. MELDRUM. 1991. Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus. Neurosci. Lett. 133: 287-290.
31. 31. MORRIS, R. G. M. 1984. Development of a water maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11: 47-60.
32. 32. MORRIS, R. G. M. 1991. Spatial localization does not require the presence of local cues. Learning Motiv. 12: 239-260.
33. 33. MORRIS, R. G. M., P. GARRUD, J. N. P. RAWLINS AND J. O'KEEFE. 1982. Place navigation is impaired in rats with hippocampal lesions. Nature 297: 681-683.
34. 34. MORRISON, R. 1993. Epidermal growth factor: structure, expression, and functions in the central nervous system. In (S. E. Loughlin and J. H. Fallon, Eds.), Neurotrophic Factors, pp. 339-357. Academic Press, San Diego.
35. 35. NADLER, J., B. PERRY AND C. COTMAN. 1978. Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature. 271: 676-677.
36. 36. NISHIDA, E. AND Y. GOTOH. 1993. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem. Sci. 18: 128-131.
37. 37. NUNN, J. A., E. LEPEILLET, C. A. NETTO, H. HODGES, J. A. GRAY AND B. S. MELDRUM. 1994. (1994) Global ischaemia: Hippocampal pathology and spatial deficits in the water maze. Behav. Brain Res. 62: 41-54.
38. 38. OHNO, M., T. YAMAMOTO AND S. WATANABE. 1991. Effect of staurosporine, a protein kinase inhibitor, on impairment of working memory in rats exposed to cerebral ischemia. Eur. J. Pharmacol. 204: 113-116.
39. 39. O'RouRKE, D. M., A. J. SAYKIN, J. J. GILHOOL, R. HARLEY, M. J. O'CoNNOR AND M. R. SPERLING. 1993. Unilateral hemispheric memory and hippocampal neuronal density in temporal lobe epilepsy. Neurosurgery. 32: 574-580.
40. 40. ROTHSTEIN, J. D., L. JIN, M. DYKES-HOBERG AND R. W. KUNCL. 1993. Chrome inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA 90: 6591-6595.
41. 41. SCHENCK, F. AND R. G. M. MORRIS. 1985. Dissociation between components of spatial memory in rats after recovery from the effects of retrohippocampal lesions. Exp. Brain Res. 58: 11-28.
42. 42. STAFSTROM, C. E., A. CHONOPOULOS, S. THURBER, J. L. THOMPSON AND G. L. HOLMES. 1993. Age-dependent cognitive and behavioral deficits after kainic acid seizures. Epilepsia. 34: 420-432.
43. 43. STEIN-BEHRENS, B., M. P. MATTSON, I. CHANG, M. YEH AND R. M. SAPOLSKY. 1994. Stress excacerbates neuron loss and cytoskeletal pathology in the hippocampus. J. Neurosci. 14: 5373-5380.
44. 44. TEITELBAUM, J. S., R. J. ZATORRE, S. CARPENTER ET AL. 1990. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N. Engl. J. Med. 322: 1781-1787.
45. 45. THOMAS, K. A. 1993. Biochemistry and molecular biology of fibroblast growth factors. In (Loughlin SE, Fallon JH, eds) Neurotrophic Factors, Academic Press, San Diego, pp 285-312.
46. 46. WEISS, J. H., D. M. HARTLEY, J. KOH AND D. W. CHOI. 1990. The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity. Science. 247: 1474-1477.